Acute sarcoidosis in a multiple sclerosis patient after alemtuzumab treatment.

CONCLUSION: Our case highlights the profound effect of alemtuzumab on the immune system and its possible risk for autoimmune complications. PMID: 30307371 [PubMed - as supplied by publisher]
Source: Nuklearmedizin - Category: Radiology Authors: Tags: Mult Scler Source Type: research